top of page
Trials are being held to evaluate the efficacy of HSCT for MS.
StarMS research study
The StarMS trial aims to compare the efficacy and safety profile of Autologous Haematopoietic Stem Cell Transplantation (aHSCT) vs 4 ‘highly effective’ Disease Modifying Therapies (DMTs) – Ocrelizumab, Alemtuzumab, Cladribine and Ofatumumab.
bottom of page